Clinical Trial Update: Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial is evaluating ferric derisomaltose for iron-deficiency anemia in children aged 0 to under 18; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron Deficiency, Anaemia in Children | Phase 3 | Status: RECRUITING